Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial

Michael Anstead, Sonya L. Heltshe, Umer Khan, Joseph T. Barbieri, Markus Langkamp, Gerd Döring, Shimoni Dharia, Ronald L. Gibson, Miriam M. Treggiari, James Lymp, Margaret Rosenfeld, Bonnie Ramsey

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial'. Together they form a unique fingerprint.

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science